23 May 2013
Keywords: ec, approves, bayer, nexavar, rcc, german, drugmaker
Article | 31 July 2006
German drugmaker Bayer AG says that the European Commission has granted marketing authorization for its oral drug Nexavar (sorafenib) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2006
31 July 2006
24 July 2006
© 2013 thepharmaletter.com